ClinicalTrials.Veeva

Menu

Gastroesophageal Reflux Disease in Azerbaijan

S

Sevda Aghayeva

Status

Completed

Conditions

Gastroesophageal Reflux Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03616119
QastroHep

Details and patient eligibility

About

To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended to evaluate the prevalence of the disease in the regions as well as the capital by cluster sampling ,ethitology and to compare the outcomes depending on the geographical location.

Full description

It is an observational, nationwide study. The GERD questionnaire (1994) requested from Mayo clinic, was received and validated. The questionnaire was translated by 3 individuals from english to azeri and back trasnlated by 3 native english speakers.

Power analysis was performed. The research was presented for the approval to Ethical Committee of Azerbaijan Medical University.

Prior to the actual study, a pilot study with smaller number of participants was performed and the results were evaluated.

Cluster sampling methodology was provided by the statistical department of Azerbaijan Medical University.

110 employees were hired for using a survey in different regions of Azerbaijan. Written consent was obtained from every person evaluated. Statistical ananlysis was performed.

Enrollment

1,000 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 18-80
  • Both genders
  • Hearburn
  • Belching
  • Regurgitation

Exclusion criteria

  • protom pomp inhibitor use
  • antibiotic use in the last 4 weeks
  • upper GI surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems